PairBook
HomeEXC › EXC vs MRNA

EXC vs MRNA: Correlation

Exelon (EXC) and Moderna (MRNA) show a negative relationship: their 3-year correlation of weekly returns is -0.20.

Data as of 2026-08-27 · refreshed every trading day · weekly returns · methodology

Correlation (3Y)
-0.20
negative
Correlation (1Y)
-0.23
last 12 months
Correlation (5Y)
-0.08
long-run
Ann. covariance
-394.6
%² · weekly, annualized

How correlated are EXC and MRNA?

Across a 3-year window, the weekly returns of EXC and MRNA correlate at -0.20, negative, meaning they tend to move in opposite directions. Little has changed lately, as the 1-year reading of -0.23 lands near the 3-year figure. Stretching to 5 years gives -0.08, with an annualized covariance of -394.6 %².

By 3-year correlation, MRNA places #25 of the 41 assets tracked against EXC. Their recent paths diverged sharply: over the last 12 months MRNA outperformed by 467.1 percentage points (+1.7% for EXC against +468.8% for MRNA). This link changes with the market regime, having swung between -0.50 and 0.43 on a rolling one-year basis. Risk is not evenly split, since MRNA carries 5.2 times the volatility of the other side.

+1.0+0.50-0.5-1.020232026-08-27
Rolling one-year correlation of weekly returns over the past three years.
How is this computed?

Pearson correlation on weekly returns: ρ(A,B) = cov(rA, rB) / (σA · σB), over windows of 52, 156 and 260 weeks. Covariance is annualized (×52) and expressed in %². Full definitions on the methodology page.

EXC vs MRNA: side by side

EXC (Exelon)MRNA (Moderna)
1-year return+1.7%+468.8%
5-year return+48.1%-61.5%
Volatility (ann.)19.4%100.7%
Beta vs S&P 500-0.050.98
Max drawdown (3Y)-18.9%-86.6%
Market cap$45.3B$57.0B
P/E (trailing)16.3
Dividend yield3.69%0.00%
Sector / categoryUtilitiesHealth Care
Higher yield: EXC 3.69% vs 0.00%Smaller drawdown: EXC -18.9% vs -86.6%Higher 5y return: EXC +48.1% vs -61.5%
-6%0%+477%2025-09-052026-08-27
Price paths over the last 12 months, both indexed to 100 at the start (weekly closes). EXC · MRNA

Year-by-year returns

YearEXCMRNA
2022+8.3%-29.3%
2023-14.0%-44.6%
2024+9.2%-58.2%
2025+20.0%-29.1%
2026+2.7%+384.1%

Calendar-year price returns; the current year is year-to-date as of the data date above.

Are EXC and MRNA good diversifiers for each other?

Yes: at -0.20, the two have gone their own ways historically, which is what genuine diversification looks like.

FAQ

What is the correlation between EXC and MRNA?

The EXC/MRNA correlation stands at -0.20 on a 3-year window (1 year: -0.23, 5 years: -0.08), computed from weekly returns as of 2026-08-27.

Is MRNA a good diversifier for EXC?

Yes: at -0.20, the two have gone their own ways historically, which is what genuine diversification looks like.

What does a correlation of -0.20 mean?

A reading of -0.20 sits on a scale from −1 (opposite moves) through 0 (unrelated) to +1 (identical moves). Correlation captures direction, not magnitude or performance.

Use this data

JSON API · no key required
$ curl https://www.pairbook.io/api/v1/pairs/exc-vs-mrna.json

EXC vs MRNA: 3-year weekly correlation -0.20EXC vs MRNA-0.20

Markdown for the live badge, attribution link included:

[![EXC vs MRNA correlation](https://www.pairbook.io/api/v1/badge/exc-vs-mrna.svg)](https://www.pairbook.io/pair/exc-vs-mrna/)

No key needed, free to use. Full endpoint list in the API documentation.

Related comparisons

Hubs: EXC correlations · MRNA correlations